Showing 1 - 20 results of 1,629 for search '(((( myeloid cell decrease ) OR ( myeloid small decrease ))) OR ( euploid fold decrease ))', query time: 0.95s Refine Results
  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6

    Table1_Effects of the PLK4 inhibitor Centrinone on the biological behaviors of acute myeloid leukemia cell lines.XLSX by Xing-Ru Mu (13252227)

    Published 2022
    “…<p>Polo-like kinase 4 (PLK4), a key regulator of centriole biogenesis, is frequently overexpressed in cancer cells. However, roles and the mechanism of PLK4 in the leukemiagenesis of acute myeloid leukemia (AML) remain unclear. …”
  7. 7

    DataSheet1_Effects of the PLK4 inhibitor Centrinone on the biological behaviors of acute myeloid leukemia cell lines.PDF by Xing-Ru Mu (13252227)

    Published 2022
    “…<p>Polo-like kinase 4 (PLK4), a key regulator of centriole biogenesis, is frequently overexpressed in cancer cells. However, roles and the mechanism of PLK4 in the leukemiagenesis of acute myeloid leukemia (AML) remain unclear. …”
  8. 8

    Limited differential expression of miRNAs and other small RNAs in LPS-stimulated human monocytes by Daniel Lu (6504041)

    Published 2019
    “…<div><p>Monocytes are a distinct subset of myeloid cells with diverse functions in early inflammatory immune modulation. …”
  9. 9

    Table_1_A risk score combining co-expression modules related to myeloid cells and alternative splicing associates with response to PD-1/PD-L1 blockade in non-small cell lung cancer... by Yichao Han (8384574)

    Published 2023
    “…Background<p>Comprehensive analysis of transcriptomic profiles of non-small cell lung cancer (NSCLC) may provide novel evidence for biomarkers associated with response to PD-1/PD-L1 immune checkpoint blockade (ICB).…”
  10. 10

    DataSheet_1_A risk score combining co-expression modules related to myeloid cells and alternative splicing associates with response to PD-1/PD-L1 blockade in non-small cell lung ca... by Yichao Han (8384574)

    Published 2023
    “…Background<p>Comprehensive analysis of transcriptomic profiles of non-small cell lung cancer (NSCLC) may provide novel evidence for biomarkers associated with response to PD-1/PD-L1 immune checkpoint blockade (ICB).…”
  11. 11
  12. 12

    Related Article from Myeloid Suppressors Decrease Melanoma Survival by Abating Tumor-Fighting T Cells by Rolf Kiessling (149724)

    Published 2023
    “…Related Article from Myeloid Suppressors Decrease Melanoma Survival by Abating Tumor-Fighting T Cells…”
  13. 13
  14. 14

    Image3_Honokiol Induces Ferroptosis by Upregulating HMOX1 in Acute Myeloid Leukemia Cells.pdf by Xingrong Lai (12526789)

    Published 2022
    “…The results showed that honokiol decreased the viability of the targeted AML cells, induced their cell cycle arrest at G0/G1 phase, and inhibited their colony-formation capacity. …”
  15. 15

    Image1_Honokiol Induces Ferroptosis by Upregulating HMOX1 in Acute Myeloid Leukemia Cells.pdf by Xingrong Lai (12526789)

    Published 2022
    “…The results showed that honokiol decreased the viability of the targeted AML cells, induced their cell cycle arrest at G0/G1 phase, and inhibited their colony-formation capacity. …”
  16. 16

    Image2_Honokiol Induces Ferroptosis by Upregulating HMOX1 in Acute Myeloid Leukemia Cells.pdf by Xingrong Lai (12526789)

    Published 2022
    “…The results showed that honokiol decreased the viability of the targeted AML cells, induced their cell cycle arrest at G0/G1 phase, and inhibited their colony-formation capacity. …”
  17. 17
  18. 18

    DataSheet1_Honokiol Induces Ferroptosis by Upregulating HMOX1 in Acute Myeloid Leukemia Cells.xlsx by Xingrong Lai (12526789)

    Published 2022
    “…The results showed that honokiol decreased the viability of the targeted AML cells, induced their cell cycle arrest at G0/G1 phase, and inhibited their colony-formation capacity. …”
  19. 19

    Table_1_Dual targeting of glutamine and serine metabolism in acute myeloid leukemia.xlsx by Kanwal M. Hameed (18386853)

    Published 2024
    “…<p>Acute myeloid leukemia (AML) is a heterogeneous hematological malignancy characterized by disrupted blood cell production and function. …”
  20. 20